These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2412235

  • 1. Immunologic heterogeneity of dihydrofolate reductase from methotrexate sensitive and resistant L1210 leukemia cells.
    Iqbal MP, Rothenberg SP, Larosa C.
    Proc Soc Exp Biol Med; 1985 Oct; 180(1):98-102. PubMed ID: 2412235
    [Abstract] [Full Text] [Related]

  • 2. Evidence for kinetic and immunologic heterogeneity of dihydrofolate reductase in L1210 leukemia cells.
    Iqbal MP, Rothenberg SP, da Costa M.
    Biochem Med Metab Biol; 1991 Oct; 46(2):196-207. PubMed ID: 1782010
    [Abstract] [Full Text] [Related]

  • 3. Identification of a high-molecular-weight nonfunctional protein in L1210 leukemia cells with common antigenic determinants to dihydrofolate reductase.
    Rothenberg SP, Iqbal MP.
    Cancer Res; 1983 Feb; 43(2):529-35. PubMed ID: 6184148
    [Abstract] [Full Text] [Related]

  • 4. Multiple forms of L1210 dihydrofolate reductase differing in affinity for methotrexate.
    Duffy TH, Beckman SB, Huennekens FM.
    Biochem Biophys Res Commun; 1984 Feb 29; 119(1):352-8. PubMed ID: 6704125
    [Abstract] [Full Text] [Related]

  • 5. A nonfunctional protein in human leukemia cells reacts with antiserum to dihydrofolate reductase from L1210 leukemia cells.
    Iqbal MP, Rothenberg SP.
    Life Sci; 1981 Aug 17; 29(7):689-96. PubMed ID: 6168882
    [No Abstract] [Full Text] [Related]

  • 6. Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation.
    Dicker AP, Waltham MC, Volkenandt M, Schweitzer BI, Otter GM, Schmid FA, Sirotnak FM, Bertino JR.
    Proc Natl Acad Sci U S A; 1993 Dec 15; 90(24):11797-801. PubMed ID: 8265628
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline.
    Wroblewski DH, Bhushan A, Xuan Y, Brinton BT, Tritton TR, Hacker MP.
    Cancer Chemother Pharmacol; 1996 Dec 15; 37(4):337-42. PubMed ID: 8548879
    [Abstract] [Full Text] [Related]

  • 9. A new fluorescent dihydrofolate reductase probe for studies of methotrexate resistance.
    Rosowsky A, Wright JE, Shapiro H, Beardsley P, Lazarus H.
    J Biol Chem; 1982 Dec 10; 257(23):14162-7. PubMed ID: 7142200
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A mechanism of resistance to methotrexate. NADPH but not NADH stimulation of methotrexate binding to dihydrofolate reductase.
    Kamen BA, Whyte-Bauer W, Bertino JR.
    Biochem Pharmacol; 1983 Jun 15; 32(12):1837-41. PubMed ID: 6882460
    [Abstract] [Full Text] [Related]

  • 13. A fluorescent analogue of methotrexate as a probe for folate antagonist molecular receptors.
    Susten SS, Kempton RJ, Black AM, Freisheim JH.
    Biochem Pharmacol; 1984 Jun 15; 33(12):1957-62. PubMed ID: 6732854
    [Abstract] [Full Text] [Related]

  • 14. Dihydrofolate reductase activity of leukemia L1210 during development of methotrexate resistance.
    Schrecker AW, Mead JA, Greenberg NH, Goldin A.
    Biochem Pharmacol; 1971 Mar 15; 20(3):716-8. PubMed ID: 5150168
    [No Abstract] [Full Text] [Related]

  • 15. Polymorphism of dihydrofolate reductase from a methotrexate-resistant subline of L1210 cells.
    Duffy TH, Beckman SB, Sato JK, Nagae H, Vitols KS, Huennekens FM.
    Adv Enzyme Regul; 1985 Mar 15; 23():3-12. PubMed ID: 4072799
    [Abstract] [Full Text] [Related]

  • 16. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB, Wick MM.
    Anticancer Drug Des; 1989 Jun 15; 4(1):79-87. PubMed ID: 2757754
    [Abstract] [Full Text] [Related]

  • 17. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
    Sirotnak FM, Moccio DM, Kelleher LE, Goutas LJ.
    Cancer Res; 1981 Nov 15; 41(11 Pt 1):4447-52. PubMed ID: 7306968
    [Abstract] [Full Text] [Related]

  • 18. Turnover of dihydrofolate reductase in rapidly dividing cells.
    Jackson RC, Huennekens FM.
    Arch Biochem Biophys; 1973 Jan 15; 154(1):192-8. PubMed ID: 4144053
    [No Abstract] [Full Text] [Related]

  • 19. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH, Barlowe CK, Goldman ID.
    Cancer Res; 1986 Feb 15; 46(2):588-93. PubMed ID: 2416428
    [Abstract] [Full Text] [Related]

  • 20. Limited effectiveness of in vitro high-dose methotrexate and leucovorin to overcome resistance in L1210 leukemia cells with elevations of dihydrofolate reductase.
    Bruckner H, Rubinoff M, Waxman S.
    Eur J Cancer (1965); 1980 Aug 15; 16(8):1057-63. PubMed ID: 6969180
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.